Takeda Pharmaceutical Co Ltd (TKPHF) balance sheet

TKPHFOTCPharmaceutical PreparationsAlso trades as TAK

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 17, 2026Score 5/30

$39.00+0.36 (+0.93%)

Close on Oct 19, 2026Market cap $134.41BP/E –Yield –

Takeda Pharmaceutical Co Ltd balance sheet

Annual Quarterly

JPY USD

Millions of JPY, except per-share data. Shares in millions.

Line item	Q4 2026 2026-03-31	Q4 2025 2025-03-31	Q4 2024 2024-03-31	Q4 2023 2023-03-31	Q4 2022 2022-03-31	Q4 2021 2021-03-31	Q4 2020 2020-03-31	Q4 2019 2019-03-31	Q4 2018 2018-03-31	Q4 2017 2017-03-31	Q4 2016 2016-03-31
Cash & Equivalents	595,054	385,113	457,800	533,530	849,695	966,222	637,614	702,093	294,522	319,455	451,426
Cash & Short-Term Investments	595,054	385,113	457,800	533,530	849,695	966,222	637,614	702,093	294,522	319,455	451,426
Receivables	844,312	709,465	668,403	649,429	696,644	783,091	757,005	741,907	420,247	–	–
Inventory	1,396,620	1,217,349	1,209,869	986,457	853,167	753,881	759,599	919,670	212,944	–	–
Other Current Assets	162,638	159,603	168,875	160,868	141,099	122,789	114,196	109,666	57,912	–	–
Total Current Assets	3,090,503	2,521,192	2,558,580	2,397,956	2,593,642	2,712,893	2,469,432	2,993,037	1,078,808	–	–
Property, Plant & Equipment	–	–	–	1,691,229	1,582,800	1,453,917	1,386,370	1,331,931	536,801	–	–
Operating Lease Right-of-Use Assets	483,120	481,492	533,403	410,274	407,938	386,780	347,018	–	–	–	–
Goodwill	5,809,010	5,324,430	5,410,067	4,790,723	4,407,749	4,033,917	4,012,528	4,240,251	1,029,248	–	–
Intangible Assets	3,419,348	3,631,560	4,274,682	4,269,657	3,818,544	3,909,106	4,171,361	4,751,169	1,014,264	–	–
Deferred Tax Assets	546,260	370,745	393,865	366,003	362,539	353,769	308,102	88,991	64,980	–	–
Other Long-Term Assets	77,010	70,282	51,214	63,325	82,611	100,341	103,846	87,472	77,977	–	–
Total Assets	15,511,506	14,248,344	15,108,792	13,957,750	13,178,018	12,912,293	12,821,094	13,792,773	4,106,463	–	–
Accounts Payable	491,345	475,541	547,521	649,233	516,297	343,838	318,816	327,394	240,259	–	–
Current Debt	512,157	548,939	367,251	339,600	203,993	22,153	586,817	984,946	18	–	–
Current Income Taxes Payable	97,880	133,497	109,906	232,377	200,918	145,203	182,738	150,698	67,694	–	–
Other Current Liabilities	590,152	596,283	619,174	566,689	584,949	542,651	499,386	439,055	263,930	–	–
Total Current Liabilities	2,832,074	2,506,521	2,313,103	2,481,940	2,145,730	1,773,176	2,175,898	2,553,049	737,509	–	–
Long-Term Debt	4,369,681	3,966,326	4,476,501	4,042,741	4,141,418	4,613,218	4,506,487	4,766,005	985,644	–	–
Operating Lease Liabilities	594,520	573,325	619,639	479,351	465,238	436,412	369,459	0	–	–	–
Deferred Tax Liabilities	26,804	35,153	113,777	270,620	451,511	542,852	710,147	721,456	90,725	–	–
Other Long-Term Liabilities	99,818	82,859	80,938	65,389	67,214	56,898	52,793	73,882	68,300	–	–
Total Liabilities	8,080,858	7,312,365	7,834,788	7,603,078	7,494,495	7,735,116	8,093,608	8,606,782	2,089,054	–	–
Total Debt	4,881,838	4,515,265	4,843,752	4,382,341	4,345,411	4,635,371	5,093,304	5,750,951	985,662	–	–
Common Stock	1,695,277	1,694,685	1,676,596	1,676,345	1,676,263	1,668,145	1,668,123	1,643,585	77,914	–	–
Additional Paid-In Capital	1,776,352	1,775,713	1,747,414	1,728,830	1,708,873	1,688,424	1,680,287	1,650,232	90,740	–	–
Retained Earnings	712,381	1,187,586	1,391,203	1,541,146	1,479,716	1,509,906	1,369,972	1,595,431	1,557,307	–	–
Treasury Stock	-49,128	-74,815	-51,259	-100,317	-116,007	-59,552	-87,463	-57,142	-74,373	–	–
Shareholders' Equity	7,429,441	6,935,084	7,273,264	6,354,122	5,683,019	5,173,037	4,723,483	5,181,985	1,997,424	–	–
Noncontrolling Interest	1,208	895	741	549	504	4,140	4,003	4,006	19,985	–	–
Total Equity	7,430,649	6,935,979	7,274,005	6,354,672	5,685,684	5,177,177	4,727,486	5,185,991	2,017,409	1,948,965	2,011,203
Total Liabilities & Equity	15,511,506	14,248,344	15,108,792	13,957,750	13,178,018	12,912,293	12,821,094	13,792,773	4,106,463	–	–
Shares Outstanding(shares)	1,591	1,591	1,582	1,582	1,582	1,576	1,576	1,565	795	791	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, FY2026

Gross margin: 65.1%
Operating margin: 0.1%
Net margin: -3.4%
Return on equity, FY2026: -2.1%

Financial strength

Current ratio: 1.09
Debt to equity: 0.66
Debt to assets: 31.5%
Cash to current liabilities: 21.0%

Valuation

P/E ratio: –
Price to sales: 4.68
Price to book: 2.84
Dividend yield: –